PO.CT01.04 · 临床试验
从癌症幸存者视角看数字化生存期照护规划:一项I/II期随机对照试验的定性分析
Digital survivorship care planning through the eyes of cancer survivors: A qualitative analysis of a phase I/II randomized controlled trial
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:
生存期照护计划(SCP)有助于癌症幸存者从积极治疗过渡至长期生存期。然而,传统SCP因其静态格式、有限的机构资源及实施后随访不一致,往往未被充分利用。癌症幸存者治疗后健康结局(POSTHOC)移动应用程序提高了SCP的可及性,包含健康行为的实时追踪、循证资源以及个性化的生活方式调整建议,以增强患者在癌症治疗后的自我效能与独立性。在一项I/II期临床试验中,与常规照护相比,使用POSTHOC在12周后带来了更大程度的症状负担减轻(James等)。为进一步开发能最好地满足幸存者需求的数字健康工具,本分析的主要目的是探讨癌症幸存者使用数字化SCP应用程序的体验。
方法:
对29例近期完成根治性治疗且为POSTHOC试验参与者的癌症幸存者进行了访谈。参与者通过一对一电话访谈以半结构化形式接受访谈。录音经转录后由两名独立编码者使用NVivo进行编码。主要主题和次主题经反复迭代提炼,形成最终编码本。
结果:
浮现出八个关键主题:从积极治疗过渡至长期生存期、SCP的有用性、照护团队参与、生活方式行为监测、生活方式支持、数字健康、自我管理与独立性、以及癌症的经济负担。尽管部分参与者报告了乏力、不确定感及结构化医疗支持的丧失,但多数人描述了回归正常生活的宽慰感。就锻炼和营养等生活方式行为与照护团队的互动受到重视,但处理并不一致。癌症幸存者认为SCP应用程序在促进健康行为以及增强对症状、体力活动和饮食的自我管理方面有益。为增强数字化SCP而建议的功能包括社区建设机会、更强的个性化定制以及数据的可视化呈现。尽管未被明确探询,经济压力仍作为一个主题浮现,凸显了医疗费用和收入中断的影响。
结论:
我们的研究结果强化了将生存期视为一个独特照护阶段的定性描述,这需要医疗提供者进行有意识的规划和持续参与,以确保治疗后有效的支持性照护。这些见解表明,具有吸引力、多用途并能同时促进自我管理和协作照护的癌症生存期干预措施的重要性。随着移动健康技术的进一步发展,SCP可以成为一种适应性强、交互式的工具,支持癌症幸存者向长期生存期过渡。
查看英文原文 English abstract
Background:
Survivorship care plans (SCPs) help cancer survivors in the transition from active treatment to long-term survivorship. However, traditional SCPs are often underutilized due to their static format, limited institutional resources, and inconsistent follow-up after implementation. The POST-Treatment Health Outcomes of Cancer Survivors (POSTHOC) mobile application increases SCP accessibility, includes real-time tracking of health behaviors, evidence-based resources, and personalized recommendations for lifestyle modifications to enhance patient self-efficacy and independence post-cancer treatment. In a phase I/II clinical trial, use of POSTHOC led to a greater reduction in symptom burden after 12 weeks vs. usual care (James et al.). To further develop digital health tools that best address survivors' needs, the primary aim of this analysis was to explore cancer survivors' experiences with the digital SCP application.
Methods:
Twenty-nine interviews were conducted with cancer survivors who had recently completed curative treatment and were participants in the POSTHOC trial. Participants were interviewed through a semi-structured format via one-to-one telephone interviews. Recordings were transcribed and coded by two independent coders using NVivo. Main themes and subthemes were refined iteratively to develop the final codebook.
Results:
Eight key themes emerged: transition from active treatment to long-term survivorship, usefulness of SCPs, care team engagement, monitoring lifestyle behaviors, lifestyle support, digital health, self-management and independence, and financial burden of cancer. Although some participants reported fatigue, uncertainty, and a loss of structured medical support, most described relief with returning to normalcy. Engagement with care teams regarding lifestyle behaviors, such as exercise and nutrition, was valued but inconsistently addressed. Cancer survivors found the SCP application to be beneficial for promoting healthy behaviors and enhancing self-management of symptoms, physical activity, and diet. Suggested features to enhance the digital SCP include opportunities for community building, greater customization, and visual representations of their data. Financial strain emerged as a theme despite not being explicitly probed, highlighting the impact of medical expenses and income disruption.
Conclusions:
Our findings reinforce the characterization of survivorship as a distinct phase of care, requiring intentional planning and ongoing engagement from healthcare providers to ensure effective supportive care post-treatment. These insights demonstrate the importance of cancer survivorship interventions that are engaging, versatile, and foster both self-management and collaborative care. With further advancements in mobile health technologies, the SCP can become an adaptable, interactive tool that supports cancer survivors in the transition to long-term survivorship.
利益披露 Disclosure
S. James, None..
M. S. Rangwala, None..
A. S. Kleckner, None.